OA12044A - Edible holographic products, particularly pharmaceuticals and method and apparatus for producing same. - Google Patents

Edible holographic products, particularly pharmaceuticals and method and apparatus for producing same. Download PDF

Info

Publication number: OA12044A
Authority: OA; OAPI
Prior art keywords: dosage form; holographie; core; coating; production method
Prior art date: 1999-08-05

Application number

OA1200200031A

Other languages

English (en)

Inventor

Eric Begleiter

Original Assignee

Dimensional Foods Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-08-05

Filing date

2000-08-03

Publication date

2003-08-25

2000-08-03 Application filed by Dimensional Foods Corp filed Critical Dimensional Foods Corp

2003-08-25 Publication of OA12044A publication Critical patent/OA12044A/en

Links

238000000034 method Methods 0.000 title claims description 29
239000003814 drug Substances 0.000 title description 8
239000002552 dosage form Substances 0.000 claims abstract description 219
238000012546 transfer Methods 0.000 claims abstract description 71
238000000576 coating method Methods 0.000 claims abstract description 66
239000011248 coating agent Substances 0.000 claims abstract description 59
239000000463 material Substances 0.000 claims abstract description 43
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims abstract description 36
235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims abstract description 35
230000000694 effects Effects 0.000 claims abstract description 28
239000003086 colorant Substances 0.000 claims abstract description 15
239000013543 active substance Substances 0.000 claims abstract description 13
239000007864 aqueous solution Substances 0.000 claims abstract description 9
230000008859 change Effects 0.000 claims abstract description 7
239000004014 plasticizer Substances 0.000 claims abstract description 6
238000001816 cooling Methods 0.000 claims abstract description 5
238000004519 manufacturing process Methods 0.000 claims description 42
239000002775 capsule Substances 0.000 claims description 19
238000003825 pressing Methods 0.000 claims description 17
235000013305 food Nutrition 0.000 claims description 15
239000001993 wax Substances 0.000 claims description 14
239000000203 mixture Substances 0.000 claims description 11
239000007787 solid Substances 0.000 claims description 10
238000010438 heat treatment Methods 0.000 claims description 8
238000002844 melting Methods 0.000 claims description 8
230000008018 melting Effects 0.000 claims description 8
229920002678 cellulose Polymers 0.000 claims description 7
239000001913 cellulose Substances 0.000 claims description 6
108010010803 Gelatin Proteins 0.000 claims description 5
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 5
229920000159 gelatin Polymers 0.000 claims description 5
235000019322 gelatine Nutrition 0.000 claims description 5
235000011852 gelatine desserts Nutrition 0.000 claims description 5
229920000881 Modified starch Polymers 0.000 claims description 4
239000008121 dextrose Substances 0.000 claims description 4
239000008273 gelatin Substances 0.000 claims description 4
235000000346 sugar Nutrition 0.000 claims description 4
229920001938 Vegetable gum Polymers 0.000 claims description 3
206010003591 Ataxia Diseases 0.000 claims description 2
206010010947 Coordination abnormal Diseases 0.000 claims description 2
208000016290 incoordination Diseases 0.000 claims description 2
239000000126 substance Substances 0.000 claims description 2
SGPGESCZOCHFCL-UHFFFAOYSA-N Tilisolol hydrochloride Chemical compound [Cl-].C1=CC=C2C(=O)N(C)C=C(OCC(O)C[NH2+]C(C)(C)C)C2=C1 SGPGESCZOCHFCL-UHFFFAOYSA-N 0.000 claims 18
PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims 2
239000002131 composite material Substances 0.000 claims 2
241000206607 Porphyra umbilicalis Species 0.000 claims 1
238000010924 continuous production Methods 0.000 claims 1
229910052759 nickel Inorganic materials 0.000 claims 1
230000000007 visual effect Effects 0.000 abstract description 7
239000004094 surface-active agent Substances 0.000 abstract description 6
238000005562 fading Methods 0.000 abstract description 4
-1 strengtheners Substances 0.000 abstract description 4
239000000654 additive Substances 0.000 abstract 1
230000001464 adherent effect Effects 0.000 abstract 1
239000011162 core material Substances 0.000 description 62
239000003826 tablet Substances 0.000 description 54
239000010410 layer Substances 0.000 description 52
239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 31
UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 31
239000003570 air Substances 0.000 description 12
URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 12
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
238000003860 storage Methods 0.000 description 11
229920002153 Hydroxypropyl cellulose Polymers 0.000 description 10
235000010977 hydroxypropyl cellulose Nutrition 0.000 description 10
239000000243 solution Substances 0.000 description 9
229910003460 diamond Inorganic materials 0.000 description 7
239000010432 diamond Substances 0.000 description 7
230000008569 process Effects 0.000 description 7
GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 6
239000001087 glyceryl triacetate Substances 0.000 description 6
235000013773 glyceryl triacetate Nutrition 0.000 description 6
230000007246 mechanism Effects 0.000 description 6
229960002622 triacetin Drugs 0.000 description 6
229920001800 Shellac Polymers 0.000 description 5
229920002472 Starch Polymers 0.000 description 5
235000010980 cellulose Nutrition 0.000 description 5
239000000843 powder Substances 0.000 description 5
230000004044 response Effects 0.000 description 5
239000004208 shellac Substances 0.000 description 5
ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 5
229940113147 shellac Drugs 0.000 description 5
235000013874 shellac Nutrition 0.000 description 5
235000019698 starch Nutrition 0.000 description 5
239000011247 coating layer Substances 0.000 description 4
235000009508 confectionery Nutrition 0.000 description 4
238000010276 construction Methods 0.000 description 4
239000007902 hard capsule Substances 0.000 description 4
239000000546 pharmaceutical excipient Substances 0.000 description 4
239000007921 spray Substances 0.000 description 4
238000012360 testing method Methods 0.000 description 4
230000002411 adverse Effects 0.000 description 3
230000008901 benefit Effects 0.000 description 3
150000001875 compounds Chemical class 0.000 description 3
230000001276 controlling effect Effects 0.000 description 3
239000000975 dye Substances 0.000 description 3
230000007613 environmental effect Effects 0.000 description 3
235000003599 food sweetener Nutrition 0.000 description 3
239000000976 ink Substances 0.000 description 3
239000012188 paraffin wax Substances 0.000 description 3
239000006187 pill Substances 0.000 description 3
238000012545 processing Methods 0.000 description 3
230000000717 retained effect Effects 0.000 description 3
239000008107 starch Substances 0.000 description 3
239000003765 sweetening agent Substances 0.000 description 3
239000004408 titanium dioxide Substances 0.000 description 3
230000004584 weight gain Effects 0.000 description 3
235000019786 weight gain Nutrition 0.000 description 3
244000215068 Acacia senegal Species 0.000 description 2
235000006491 Acacia senegal Nutrition 0.000 description 2
PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
229920000084 Gum arabic Polymers 0.000 description 2
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
229920002565 Polyethylene Glycol 400 Polymers 0.000 description 2
238000005299 abrasion Methods 0.000 description 2
238000010521 absorption reaction Methods 0.000 description 2
235000010489 acacia gum Nutrition 0.000 description 2
230000009471 action Effects 0.000 description 2
239000000853 adhesive Substances 0.000 description 2
230000001070 adhesive effect Effects 0.000 description 2
229910052782 aluminium Inorganic materials 0.000 description 2
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
239000011230 binding agent Substances 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
239000000969 carrier Substances 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
238000005336 cracking Methods 0.000 description 2
238000010586 diagram Methods 0.000 description 2
238000006073 displacement reaction Methods 0.000 description 2
239000000499 gel Substances 0.000 description 2
238000001093 holography Methods 0.000 description 2
239000001863 hydroxypropyl cellulose Substances 0.000 description 2
239000008101 lactose Substances 0.000 description 2
238000012986 modification Methods 0.000 description 2
230000004048 modification Effects 0.000 description 2
238000012544 monitoring process Methods 0.000 description 2
230000003287 optical effect Effects 0.000 description 2
239000000902 placebo Substances 0.000 description 2
239000004033 plastic Substances 0.000 description 2
229940050929 polyethylene glycol 3350 Drugs 0.000 description 2
230000002829 reductive effect Effects 0.000 description 2
230000001105 regulatory effect Effects 0.000 description 2
239000007901 soft capsule Substances 0.000 description 2
239000007909 solid dosage form Substances 0.000 description 2
150000008163 sugars Chemical class 0.000 description 2
238000003856 thermoforming Methods 0.000 description 2
OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
ZLHFONARZHCSET-UHFFFAOYSA-N 5-aminolevulinic acid hydrochloride Chemical compound Cl.NCC(=O)CCC(O)=O ZLHFONARZHCSET-UHFFFAOYSA-N 0.000 description 1
108010011485 Aspartame Proteins 0.000 description 1
229920001353 Dextrin Polymers 0.000 description 1
239000004375 Dextrin Substances 0.000 description 1
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
102000009123 Fibrin Human genes 0.000 description 1
108010073385 Fibrin Proteins 0.000 description 1
BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
229930091371 Fructose Natural products 0.000 description 1
239000005715 Fructose Substances 0.000 description 1
RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
241000257303 Hymenoptera Species 0.000 description 1
GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
240000008042 Zea mays Species 0.000 description 1
235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
235000002017 Zea mays subsp mays Nutrition 0.000 description 1
PLWGQJAQEAMLSC-RJMJUYIDSA-N [Ti].OC1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@H](O2)CO)[C@H](O1)CO Chemical compound [Ti].OC1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@H](O2)CO)[C@H](O1)CO PLWGQJAQEAMLSC-RJMJUYIDSA-N 0.000 description 1
239000002253 acid Substances 0.000 description 1
239000004480 active ingredient Substances 0.000 description 1
239000011149 active material Substances 0.000 description 1
230000002009 allergenic effect Effects 0.000 description 1
239000012080 ambient air Substances 0.000 description 1
230000003466 anti-cipated effect Effects 0.000 description 1
239000000605 aspartame Substances 0.000 description 1
235000010357 aspartame Nutrition 0.000 description 1
IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
229960003438 aspartame Drugs 0.000 description 1
230000004888 barrier function Effects 0.000 description 1
XMQFTWRPUQYINF-UHFFFAOYSA-N bensulfuron-methyl Chemical compound COC(=O)C1=CC=CC=C1CS(=O)(=O)NC(=O)NC1=NC(OC)=CC(OC)=N1 XMQFTWRPUQYINF-UHFFFAOYSA-N 0.000 description 1
GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
230000005587 bubbling Effects 0.000 description 1
239000000872 buffer Substances 0.000 description 1
239000007894 caplet Substances 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
235000014633 carbohydrates Nutrition 0.000 description 1
239000005018 casein Substances 0.000 description 1
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
235000021240 caseins Nutrition 0.000 description 1
OIQPTROHQCGFEF-UHFFFAOYSA-L chembl1371409 Chemical compound [Na+].[Na+].OC1=CC=C2C=C(S([O-])(=O)=O)C=CC2=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 OIQPTROHQCGFEF-UHFFFAOYSA-L 0.000 description 1
CEZCCHQBSQPRMU-UHFFFAOYSA-L chembl174821 Chemical compound [Na+].[Na+].COC1=CC(S([O-])(=O)=O)=C(C)C=C1N=NC1=C(O)C=CC2=CC(S([O-])(=O)=O)=CC=C12 CEZCCHQBSQPRMU-UHFFFAOYSA-L 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
239000007891 compressed tablet Substances 0.000 description 1
238000007906 compression Methods 0.000 description 1
230000006835 compression Effects 0.000 description 1
239000000470 constituent Substances 0.000 description 1
235000005822 corn Nutrition 0.000 description 1
230000000994 depressogenic effect Effects 0.000 description 1
238000013461 design Methods 0.000 description 1
230000001627 detrimental effect Effects 0.000 description 1
235000019425 dextrin Nutrition 0.000 description 1
235000005911 diet Nutrition 0.000 description 1
230000037213 diet Effects 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
238000009826 distribution Methods 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
239000003925 fat Substances 0.000 description 1
229950003499 fibrin Drugs 0.000 description 1
239000006260 foam Substances 0.000 description 1
229920001821 foam rubber Polymers 0.000 description 1
230000037406 food intake Effects 0.000 description 1
238000009472 formulation Methods 0.000 description 1
238000011990 functional testing Methods 0.000 description 1
239000007903 gelatin capsule Substances 0.000 description 1
238000007429 general method Methods 0.000 description 1
239000008103 glucose Substances 0.000 description 1
150000004676 glycans Chemical class 0.000 description 1
235000011187 glycerol Nutrition 0.000 description 1
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
229910052737 gold Inorganic materials 0.000 description 1
239000010931 gold Substances 0.000 description 1
230000005484 gravity Effects 0.000 description 1
238000005286 illumination Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
238000002347 injection Methods 0.000 description 1
230000002452 interceptive effect Effects 0.000 description 1
238000010030 laminating Methods 0.000 description 1
238000003475 lamination Methods 0.000 description 1
239000007788 liquid Substances 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
239000010445 mica Substances 0.000 description 1
229910052618 mica group Inorganic materials 0.000 description 1
238000002156 mixing Methods 0.000 description 1
239000000820 nonprescription drug Substances 0.000 description 1
235000016709 nutrition Nutrition 0.000 description 1
239000003921 oil Substances 0.000 description 1
238000004806 packaging method and process Methods 0.000 description 1
238000004091 panning Methods 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
229940124531 pharmaceutical excipient Drugs 0.000 description 1
229920001184 polypeptide Polymers 0.000 description 1
229920001282 polysaccharide Polymers 0.000 description 1
239000005017 polysaccharide Substances 0.000 description 1
238000009702 powder compression Methods 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
235000018102 proteins Nutrition 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
229910052709 silver Inorganic materials 0.000 description 1
239000004332 silver Substances 0.000 description 1
239000002904 solvent Substances 0.000 description 1
238000005507 spraying Methods 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
230000009747 swallowing Effects 0.000 description 1
239000006188 syrup Substances 0.000 description 1
235000020357 syrup Nutrition 0.000 description 1
239000002562 thickening agent Substances 0.000 description 1
239000010936 titanium Substances 0.000 description 1
229910052719 titanium Inorganic materials 0.000 description 1
230000007306 turnover Effects 0.000 description 1
238000009827 uniform distribution Methods 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/005—Coating of tablets or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/007—Marking tablets or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
- B—PERFORMING OPERATIONS; TRANSPORTING
- B30—PRESSES
- B30B—PRESSES IN GENERAL
- B30B11/00—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses
- B30B11/02—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses using a ram exerting pressure on the material in a moulding space
- B30B11/08—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses using a ram exerting pressure on the material in a moulding space co-operating with moulds carried by a turntable
- B—PERFORMING OPERATIONS; TRANSPORTING
- B30—PRESSES
- B30B—PRESSES IN GENERAL
- B30B11/00—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses
- B30B11/02—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses using a ram exerting pressure on the material in a moulding space
- B30B11/14—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses using a ram exerting pressure on the material in a moulding space co-operating with moulds on a movable carrier other than a turntable or a rotating drum
- B—PERFORMING OPERATIONS; TRANSPORTING
- B30—PRESSES
- B30B—PRESSES IN GENERAL
- B30B15/00—Details of, or accessories for, presses; Auxiliary measures in connection with pressing
- B30B15/06—Platens or press rams
- B30B15/065—Press rams
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03H—HOLOGRAPHIC PROCESSES OR APPARATUS
- G03H1/00—Holographic processes or apparatus using light, infrared or ultraviolet waves for obtaining holograms or for obtaining an image from them; Details peculiar thereto
- G03H1/02—Details of features involved during the holographic process; Replication of holograms without interference recording
- G03H1/024—Hologram nature or properties
- G03H1/0244—Surface relief holograms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J2205/00—General identification or selection means
- A61J2205/20—Colour codes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J2205/00—General identification or selection means
- A61J2205/40—General identification or selection means by shape or form, e.g. by using shape recognition
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03H—HOLOGRAPHIC PROCESSES OR APPARATUS
- G03H1/00—Holographic processes or apparatus using light, infrared or ultraviolet waves for obtaining holograms or for obtaining an image from them; Details peculiar thereto
- G03H1/0005—Adaptation of holography to specific applications
- G03H2001/0055—Adaptation of holography to specific applications in advertising or decorative art
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03H—HOLOGRAPHIC PROCESSES OR APPARATUS
- G03H2270/00—Substrate bearing the hologram
- G03H2270/10—Composition

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Mechanical Engineering (AREA)
Physics & Mathematics (AREA)
General Physics & Mathematics (AREA)
Medicinal Preparation (AREA)
General Preparation And Processing Of Foods (AREA)
Holo Graphy (AREA)
Diffracting Gratings Or Hologram Optical Elements (AREA)
Medical Preparation Storing Or Oral Administration Devices (AREA)

OA1200200031A 1999-08-05 2000-08-03 Edible holographic products, particularly pharmaceuticals and method and apparatus for producing same. OA12044A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US14740699P	1999-08-05	1999-08-05

Publications (1)

Publication Number	Publication Date
OA12044A true OA12044A (en)	2003-08-25

Family

ID=22521454

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
OA1200200031A OA12044A (en)	1999-08-05	2000-08-03	Edible holographic products, particularly pharmaceuticals and method and apparatus for producing same.

Country Status (37)

Country	Link
US (2)	US7083805B2 (is)
EP (1)	EP1206280A4 (is)
JP (1)	JP2003506415A (is)
KR (1)	KR20020059358A (is)
CN (2)	CN1216643C (is)
AP (1)	AP2002002434A0 (is)
AR (1)	AR028158A1 (is)
AU (1)	AU772936C (is)
BG (1)	BG106424A (is)
BR (1)	BR0012920A (is)
CA (1)	CA2378591A1 (is)
CO (1)	CO5200853A1 (is)
CR (1)	CR6572A (is)
CZ (1)	CZ2002207A3 (is)
EA (1)	EA004895B1 (is)
EE (1)	EE200200058A (is)
GE (1)	GEP20043376B (is)
GT (1)	GT200000126A (is)
HK (1)	HK1048437A1 (is)
HN (1)	HN2000000165A (is)
HR (1)	HRP20020199A2 (is)
HU (1)	HUP0203796A2 (is)
IL (1)	IL147943A0 (is)
IS (1)	IS6244A (is)
MX (1)	MXPA02001176A (is)
NO (1)	NO20020545L (is)
NZ (1)	NZ516741A (is)
OA (1)	OA12044A (is)
PA (1)	PA8499001A1 (is)
PE (1)	PE20010664A1 (is)
PL (1)	PL353615A1 (is)
SK (1)	SK1792002A3 (is)
TR (1)	TR200200309T2 (is)
UY (1)	UY26270A1 (is)
WO (1)	WO2001010464A1 (is)
YU (1)	YU7602A (is)
ZA (1)	ZA200200605B (is)

Families Citing this family (123)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2003005839A2 (en)	1999-08-05	2003-01-23	Dimensional Foods Corporation	Edibles containing edible optical elements and methods
US20060226234A1 (en) *	2003-06-11	2006-10-12	Kettinger Frederick R	Pharmaceutical dosage forms having overt and covert markings for identification and authentification
US7431956B2 (en)	2003-06-20	2008-10-07	Sensient Imaging Technologies, Inc.	Food grade colored fluids for printing on edible substrates
US8235302B2 (en)	2004-04-20	2012-08-07	Nanolnk, Inc.	Identification features
JP2008502370A (ja)	2004-06-10	2008-01-31	センシエントイメージングテクノロジーズインコーポレイテッド	可食性基材への印刷に用いる食品用インクジェットインク液
GB0419990D0 (en) *	2004-09-09	2004-10-13	Suisse Electronique Microtech	Marking articles
US20060087051A1 (en) *	2004-10-27	2006-04-27	Bunick Frank J	Dosage forms having a microreliefed surface and methods and apparatus for their production
US20070281022A1 (en) *	2004-10-27	2007-12-06	Bunick Frank J	Dosage forms having a microreliefed surface and methods and apparatus for their production
US20060088593A1 (en) *	2004-10-27	2006-04-27	Bunick Frank J	Dosage forms having a microreliefed surface and methods and apparatus for their production
US20070190133A1 (en) *	2004-10-27	2007-08-16	Bunick Frank J	Dosage forms having a microreliefed surface and methods and apparatus for their production
US20060088587A1 (en) *	2004-10-27	2006-04-27	Bunick Frank J	Dosage forms having a microreliefed surface and methods and apparatus for their production
US8383159B2 (en)	2004-10-27	2013-02-26	Mcneil-Ppc, Inc.	Dosage forms having a microreliefed surface and methods and apparatus for their production
US20060088586A1 (en) *	2004-10-27	2006-04-27	Bunick Frank J	Dosage forms having a microreliefed surface and methods and apparatus for their production
US20100297027A1 (en) *	2004-12-20	2010-11-25	Nanolnk, Inc.	Overt authentication features for compositions and objects and methods of fabrication and verification thereof
US8069782B2 (en) *	2004-12-20	2011-12-06	Nanoink, Inc.	Stamps with micrometer- and nanometer-scale features and methods of fabrication thereof
US20100294147A1 (en) *	2004-12-20	2010-11-25	Nanoink, Inc.	Apparatus and methods for preparing identification features including pharmaceutical applications
WO2006106815A1 (ja) *	2005-03-31	2006-10-12	Takeda Pharmaceutical Company Limited	錠剤
US8802183B2 (en)	2005-04-28	2014-08-12	Proteus Digital Health, Inc.	Communication system with enhanced partial power source and method of manufacturing same
US8730031B2 (en)	2005-04-28	2014-05-20	Proteus Digital Health, Inc.	Communication system using an implantable device
US9198608B2 (en)	2005-04-28	2015-12-01	Proteus Digital Health, Inc.	Communication system incorporated in a container
EP2671508B1 (en) *	2005-04-28	2020-09-16	Proteus Digital Health, Inc.	Pharma-informatics system
US8836513B2 (en)	2006-04-28	2014-09-16	Proteus Digital Health, Inc.	Communication system incorporated in an ingestible product
US8912908B2 (en)	2005-04-28	2014-12-16	Proteus Digital Health, Inc.	Communication system with remote activation
WO2007007659A1 (ja) *	2005-07-08	2007-01-18	Takeda Pharmaceutical Company Limited	錠剤
US8547248B2 (en) *	2005-09-01	2013-10-01	Proteus Digital Health, Inc.	Implantable zero-wire communications system
JP2007117181A (ja) *	2005-10-25	2007-05-17	Nissei Kosan Kk	軟質カプセル剤
US7796335B2 (en) *	2006-04-03	2010-09-14	William Karszes	Microlens windows and interphased images for packaging and printing and methods for manufacture
USD553733S1 (en) *	2006-04-07	2007-10-23	Novartis Ag	Tablet
CN105468895A (zh) *	2006-05-02	2016-04-06	普罗透斯数字保健公司	患者定制的治疗方案
DE102007026957B4 (de) *	2006-06-13	2012-04-05	Csem Centre Suisse D'electronique Et De Microtechnique S.A.	Pharmazeutische Tabletten mit diffraktiver Mikrostruktur
EP2026741B1 (de) *	2006-06-13	2015-08-12	CSEM Centre Suisse d'Electronique et de Microtechnique SA - Recherche et Développement	Pharmazeutische Tabletten mit diffraktiver Mikrostruktur und Presswerkzeuge zur Herstellung solcher Tabletten
DE102007026958B4 (de) *	2006-06-13	2014-10-09	Csem Centre Suisse D'electronique Et De Microtechnique S.A.	Presswerkzeug mit diffraktiver Mikrostruktur und Verfahren zur Herstellung eines solchen Werkzeugs sowie Tablettierungspresse
CH699631B1 (de)	2007-01-12	2010-04-15	Suisse Electronique Microtech	Realisieren einer diffraktiven Mikrostruktur in eine Pillenoberfläche.
US20080020037A1 (en) *	2006-07-11	2008-01-24	Robertson Timothy L	Acoustic Pharma-Informatics System
US8945005B2 (en)	2006-10-25	2015-02-03	Proteus Digital Health, Inc.	Controlled activation ingestible identifier
US20100046902A1 (en)	2006-11-03	2010-02-25	Trustees Of Tufts College	Biopolymer photonic crystals and method of manufacturing the same
EP2650112B1 (en)	2006-11-03	2016-08-24	Trustees Of Tufts College	Nanopatterned biopolymer optical device and method of manufacturing the same
US20100096763A1 (en) *	2006-11-03	2010-04-22	Trustees Of Tufts College	Biopolymer optofluidic device and method of manufacturing the same
CA2704768A1 (en) *	2006-11-03	2008-10-23	Trustees Of Tufts College	Biopolymer sensor and method of manufacturing the same
EP2069004A4 (en)	2006-11-20	2014-07-09	Proteus Digital Health Inc	PERSONAL HEALTH SIGNAL RECEIVERS WITH ACTIVE SIGNAL PROCESSING
CA2676407A1 (en)	2007-02-01	2008-08-07	Proteus Biomedical, Inc.	Ingestible event marker systems
EP3236524A1 (en)	2007-02-14	2017-10-25	Proteus Digital Health, Inc.	In-body power source having high surface area electrode
DK1958620T3 (da)	2007-02-16	2012-07-30	Suisse Electronique Microtech	Verificeringsfremgangsmåde
WO2008112577A1 (en)	2007-03-09	2008-09-18	Proteus Biomedical, Inc.	In-body device having a multi-directional transmitter
US9270025B2 (en)	2007-03-09	2016-02-23	Proteus Digital Health, Inc.	In-body device having deployable antenna
US8115618B2 (en) *	2007-05-24	2012-02-14	Proteus Biomedical, Inc.	RFID antenna for in-body device
US20090004231A1 (en)	2007-06-30	2009-01-01	Popp Shane M	Pharmaceutical dosage forms fabricated with nanomaterials for quality monitoring
IL185130A0 (en) *	2007-08-08	2008-01-06	Semi Conductor Devices An Elbi	Thermal based system and method for detecting counterfeit drugs
PT2192946T (pt)	2007-09-25	2022-11-17	Otsuka Pharma Co Ltd	Dispositivo no corpo com amplificação de sinal dipolo virtual
GB0719095D0 (en) *	2007-10-01	2007-11-07	Bioprogress Technology Ltd	Indelibly marked polymeric films
WO2009051805A1 (en) *	2007-10-17	2009-04-23	Stefan Klocke	Manufacturing solid pharmaceutical dosage forms with visible micro-and nanostructured surfaces and micro-and nanostructured pharmaceutical dosage form
US10363221B2 (en)	2007-10-17	2019-07-30	I-Property Holding Corp.	Manufacturing solid pharmaceutical dosage forms with visible micro- and nanostructured surfaces and micro- and nanostructured pharmaceutical dosage form
WO2009051794A1 (en)	2007-10-17	2009-04-23	Stefan Klocke	Pharmaceutical moire pill
US20100297228A1 (en) *	2007-10-29	2010-11-25	Nanolnk, Inc.	Universal coating for imprinting identification features
EP2206017B1 (en)	2007-11-05	2019-02-20	Trustees Of Tufts College	Fabrication of silk fibroin photonic structures by nanocontact imprinting
WO2009070773A1 (en) *	2007-11-27	2009-06-04	Proteus Biomedical, Inc.	Transbody communication systems employing communication channels
GB2455805B (en) *	2007-12-21	2009-11-18	Valtion Teknillinen	Diffractive microstructure and a method of producing the same
JP2011513865A (ja)	2008-03-05	2011-04-28	プロテウスバイオメディカルインコーポレイテッド	マルチモード通信の摂取可能なイベントマーカーおよびシステム、ならびにそれを使用する方法
US10531681B2 (en)	2008-04-25	2020-01-14	Sensient Colors Llc	Heat-triggered colorants and methods of making and using the same
FI20085611A0 (fi) *	2008-06-18	2008-06-18	Valtion Teknillinen	Indikaattori
EP2307054A4 (en) *	2008-06-18	2013-02-06	Tufts College	EDIBLE HOLOGRAPHIC SILK PRODUCTS
KR101615128B1 (ko) *	2008-07-08	2016-04-26	프로테우스 디지털 헬스, 인코포레이티드	섭취 가능한 이벤트 마커 데이터 프레임워크
US8626672B2 (en) *	2008-07-23	2014-01-07	I-Property Holding Corp.	Secure tracking of tablets
EP2320875B1 (en)	2008-07-23	2019-07-03	I-Property Holding Corp.	Secure tracking of tablets
US8540633B2 (en) *	2008-08-13	2013-09-24	Proteus Digital Health, Inc.	Identifier circuits for generating unique identifiable indicators and techniques for producing same
US9113647B2 (en)	2008-08-29	2015-08-25	Sensient Colors Llc	Flavored and edible colored waxes and methods for precision deposition on edible substrates
US8055334B2 (en)	2008-12-11	2011-11-08	Proteus Biomedical, Inc.	Evaluation of gastrointestinal function using portable electroviscerography systems and methods of using the same
JP2012514799A (ja)	2009-01-06	2012-06-28	プロテウスバイオメディカルインコーポレイテッド	摂取に関連するバイオフィードバックおよび個別薬物療法の方法およびシステム
SG172847A1 (en)	2009-01-06	2011-08-29	Proteus Biomedical Inc	Pharmaceutical dosages delivery system
EP2396276B1 (en)	2009-02-12	2016-08-31	Trustees Of Tufts College	Nanoimprinting of silk fibroin structures for biomedical and biophotonic applications
FR2943268B1 (fr) *	2009-03-20	2014-02-28	Arcil	Moule de thermofromage a isolation thermique et procede associe.
US8540664B2 (en)	2009-03-25	2013-09-24	Proteus Digital Health, Inc.	Probablistic pharmacokinetic and pharmacodynamic modeling
SG10201810784SA (en)	2009-04-28	2018-12-28	Proteus Digital Health Inc	Highly Reliable Ingestible Event Markers And Methods For Using The Same
US9149423B2 (en)	2009-05-12	2015-10-06	Proteus Digital Health, Inc.	Ingestible event markers comprising an ingestible component
US9016875B2 (en)	2009-07-20	2015-04-28	Tufts University/Trustees Of Tufts College	All-protein implantable, resorbable reflectors
WO2011011333A2 (en) *	2009-07-20	2011-01-27	Nanoink, Inc.	Nanomolding micron and nano scale features
US9189728B2 (en)	2009-07-23	2015-11-17	I-Property Holding Corp.	Method for the authentication of dosage forms
JP2011036278A (ja) *	2009-08-06	2011-02-24	Dainippon Printing Co Ltd	医薬用カプセル
JP5493570B2 (ja) *	2009-08-06	2014-05-14	大日本印刷株式会社	医薬用カプセルの製造方法
EP2467707A4 (en)	2009-08-21	2014-12-17	Proteus Digital Health Inc	DEVICE AND METHOD FOR MEASURING BIOLOGICAL PARAMETERS
WO2011026101A2 (en)	2009-08-31	2011-03-03	Trustees Of Tufts College	Silk transistor devices
EP2485703B1 (en) *	2009-10-08	2014-12-17	Gea Pharma Systems Limited	Method and a drum coater for coating small items, such as tablets, and a coating system comprising such drum coaters
US7961014B2 (en) *	2009-10-26	2011-06-14	Analog Devices, Inc.	Apparatus and method for providing multi-mode clock signals
TWI517050B (zh)	2009-11-04	2016-01-11	普羅托斯數位健康公司	供應鏈管理之系統
UA109424C2 (uk) *	2009-12-02	2015-08-25		Фармацевтичний продукт, фармацевтична таблетка з електронним маркером і спосіб виготовлення фармацевтичної таблетки
MX2012011693A (es)	2010-04-07	2013-02-15	Proteus Digital Health Inc	Dispositivo ingerible miniatura.
TWI557672B (zh)	2010-05-19	2016-11-11	波提亞斯數位康健公司	用於從製造商跟蹤藥物直到患者之電腦系統及電腦實施之方法、用於確認將藥物給予患者的設備及方法、患者介面裝置
US20110290694A1 (en)	2010-05-27	2011-12-01	Monosol Rx, Llc	Oral film dosage form having indicia thereon
US10189616B2 (en) *	2010-08-13	2019-01-29	Daniel L. Kraft	System and methods for the production of personalized drug products
FR2966731B1 (fr) *	2010-11-03	2013-04-26	Sanofi Aventis	Forme pharmaceutique solide marquee et son procede de fabrication par marquage laser
WO2012071280A2 (en)	2010-11-22	2012-05-31	Proteus Biomedical, Inc.	Ingestible device with pharmaceutical product
EP2701668A1 (en)	2011-04-29	2014-03-05	Massachusetts Institute of Technology	Layer processing for pharmaceuticals
US9756874B2 (en)	2011-07-11	2017-09-12	Proteus Digital Health, Inc.	Masticable ingestible product and communication system therefor
WO2015112603A1 (en)	2014-01-21	2015-07-30	Proteus Digital Health, Inc.	Masticable ingestible product and communication system therefor
BR112014001397A2 (pt)	2011-07-21	2017-02-21	Proteus Biomedical Inc	dispositivo, sistema e método de comunicação móvel
US8607803B2 (en) *	2011-09-29	2013-12-17	The Procter & Gamble Company	Hair treatment process providing dispersed colors by light diffraction
US9235683B2 (en)	2011-11-09	2016-01-12	Proteus Digital Health, Inc.	Apparatus, system, and method for managing adherence to a regimen
KR20150038038A (ko)	2012-07-23	2015-04-08	프로테우스 디지털 헬스, 인코포레이티드	섭취 가능한 부품을 포함하는 섭취 가능한 이벤트 마커를 제조하기 위한 기술
US20140141078A1 (en) *	2012-09-15	2014-05-22	Jeffery K. Slaboden	Dissolvable TableT
DK2910013T3 (en)	2012-10-18	2018-08-06	Proteus Digital Health Inc	Apparatus, system and method for adaptive optimization for power output and transmit power in a power source for a communication device
TWI659994B (zh)	2013-01-29	2019-05-21	美商普羅托斯數位健康公司	高度可膨脹之聚合型薄膜及包含彼之組成物
US11744481B2 (en)	2013-03-15	2023-09-05	Otsuka Pharmaceutical Co., Ltd.	System, apparatus and methods for data collection and assessing outcomes
WO2014144738A1 (en)	2013-03-15	2014-09-18	Proteus Digital Health, Inc.	Metal detector apparatus, system, and method
WO2014160904A1 (en)	2013-03-28	2014-10-02	The Procter & Gamble Company	Hair treatment process providing dispersed colors by light diffraction
WO2014170420A1 (en)	2013-04-19	2014-10-23	Nestec S.A.	Molded food product
US9796576B2 (en)	2013-08-30	2017-10-24	Proteus Digital Health, Inc.	Container with electronically controlled interlock
US10084880B2 (en)	2013-11-04	2018-09-25	Proteus Digital Health, Inc.	Social media networking based on physiologic information
US10213960B2 (en)	2014-05-20	2019-02-26	Massachusetts Institute Of Technology	Plasticity induced bonding
KR101999492B1 (ko) *	2015-06-05	2019-07-11	시바우라 메카트로닉스 가부시끼가이샤	정제 인쇄 장치 및 정제 인쇄 방법
US11051543B2 (en)	2015-07-21	2021-07-06	Otsuka Pharmaceutical Co. Ltd.	Alginate on adhesive bilayer laminate film
CN109843149B (zh)	2016-07-22	2020-07-07	普罗秋斯数字健康公司	可摄入事件标记的电磁感测和检测
US11701298B2 (en) *	2016-10-26	2023-07-18	Holographyx Inc.	Pharmaceutical packs comprising holographic lidding material, and method of making the same
KR102605670B1 (ko)	2016-10-26	2023-11-24	오츠카 세이야쿠 가부시키가이샤	섭취 가능한 이벤트 마커를 갖는 캡슐을 제조하는 방법
JP6896431B2 (ja) *	2017-01-10	2021-06-30	株式会社Ｓｃｒｅｅｎホールディングス	粒状物、読取装置、および印刷装置
JP6865714B2 (ja) *	2018-07-03	2021-04-28	Ckd株式会社	Ｐｔｐシートの製造方法
JP6924730B2 (ja) *	2018-07-25	2021-08-25	Ckd株式会社	Ｐｔｐシートの製造方法
JP7083719B2 (ja) *	2018-07-25	2022-06-13	Ckd株式会社	Ｐｔｐシートの製造方法
JP7146547B2 (ja) *	2018-09-25	2022-10-04	株式会社Ｓｃｒｅｅｎホールディングス	示温固体製剤
JP2022524104A (ja) *	2019-03-08	2022-04-27	トライ－スターテクノロジーズ	物品にパターンを施して、その検査を行うためのシステムおよび方法
JP7423425B2 (ja)	2020-05-29	2024-01-29	エステー株式会社	錠剤
MX2023010906A (es) *	2021-03-17	2023-12-07	Actelion Pharmaceuticals Ltd	Sistema de dosificacion farmaceutica.
WO2022265911A1 (en) *	2021-06-18	2022-12-22	Lieberman Ori	Crystalline resin containing microscopic surface reliefs and methods and systems for generating the same
IT202200015474A1 (it) *	2022-07-22	2024-01-22	Lavazza Luigi Spa	Compressa per l'estrazione di una bevanda e procedimento per la sua produzione

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4031200A (en)	1975-12-15	1977-06-21	Hoffmann-La Roche Inc.	Manufacture of pharmaceutical unit dosage forms
US4029757A (en) *	1975-12-15	1977-06-14	Hoffmann-La Roche Inc.	Manufacture of pharmaceutical unit dosage forms
JPS58152813A (ja) *	1982-03-08	1983-09-10	Sumitomo Chem Co Ltd	鮮明な刻印を有する錠剤およびその製法
KR840000624A (ko) *	1982-06-02	1984-02-25	원본미기재	부식억제 페인트 조성물
US4668521A (en) *	1985-03-04	1987-05-26	Chocolate Pix, Inc.	Method of forming an image with photographic likeness on chocolate
US4668523A (en) *	1985-03-06	1987-05-26	Eric Begleiter	Holographic product
IE63321B1 (en) *	1986-02-03	1995-04-05	Elan Corp Plc	Drug delivery system
US4847090A (en)	1986-11-07	1989-07-11	Warner-Lambert Company	Confection product and method for making same
US5189531A (en)	1988-10-17	1993-02-23	August DeFazio	Hologram production
EP0771339B1 (en)	1994-07-12	2003-10-15	BPSI Holdings, Inc.	Dry moisture barrier film coating composition, method of coating substrates using the same and pharmaceutical tablets coated therewith
US5992742A (en) *	1994-08-05	1999-11-30	Sullivan; Scott L.	Pill printing and identification
US5510171A (en) *	1995-01-19	1996-04-23	Minnesota Mining And Manufacturing Company	Durable security laminate with hologram
US5834047A (en) *	1996-06-10	1998-11-10	Ahn; Sung-Ae	Method for imprinting confectionery products with edible ink
US6054158A (en) *	1998-06-23	2000-04-25	Candy Novelty Works Ltd.	Magnifying lollipop
US6103278A (en) *	1999-01-12	2000-08-15	Lluch; Alex	Lenticular lollipop
BG103081A (bg) *	1999-01-14	2000-07-31	Николай МАРЧЕВ	Метод и капсул автомат за получаване на капсули от термосвиваемо фолио
US6975765B2 (en) *	2003-05-06	2005-12-13	New Light Industries, Ltd.	Optically variable form birefringent structure and method and system and method for reading same

2000
- 2000-07-31 HN HN2000000165A patent/HN2000000165A/es unknown
- 2000-08-02 PA PA20008499001A patent/PA8499001A1/es unknown
- 2000-08-03 CN CN008113300A patent/CN1216643C/zh not_active Expired - Fee Related
- 2000-08-03 HU HU0203796A patent/HUP0203796A2/hu unknown
- 2000-08-03 GE GE4669A patent/GEP20043376B/en unknown
- 2000-08-03 BR BR0012920-8A patent/BR0012920A/pt not_active IP Right Cessation
- 2000-08-03 HR HR20020199A patent/HRP20020199A2/hr not_active Application Discontinuation
- 2000-08-03 SK SK179-2002A patent/SK1792002A3/sk not_active Application Discontinuation
- 2000-08-03 HK HK02108455.9A patent/HK1048437A1/zh unknown
- 2000-08-03 AP APAP/P/2002/002434A patent/AP2002002434A0/en unknown
- 2000-08-03 UY UY26270A patent/UY26270A1/es not_active Application Discontinuation
- 2000-08-03 AU AU65135/00A patent/AU772936C/en not_active Ceased
- 2000-08-03 EA EA200200089A patent/EA004895B1/ru not_active IP Right Cessation
- 2000-08-03 CA CA002378591A patent/CA2378591A1/en not_active Abandoned
- 2000-08-03 IL IL14794300A patent/IL147943A0/xx unknown
- 2000-08-03 EE EEP200200058A patent/EE200200058A/xx unknown
- 2000-08-03 KR KR1020027001610A patent/KR20020059358A/ko not_active Ceased
- 2000-08-03 JP JP2001514980A patent/JP2003506415A/ja active Pending
- 2000-08-03 CZ CZ2002207A patent/CZ2002207A3/cs unknown
- 2000-08-03 EP EP00952433A patent/EP1206280A4/en not_active Withdrawn
- 2000-08-03 CN CNA2004101049346A patent/CN1650844A/zh active Pending
- 2000-08-03 WO PCT/US2000/021149 patent/WO2001010464A1/en not_active Ceased
- 2000-08-03 GT GT200000126A patent/GT200000126A/es unknown
- 2000-08-03 YU YU7602A patent/YU7602A/sh unknown
- 2000-08-03 NZ NZ516741A patent/NZ516741A/en unknown
- 2000-08-03 TR TR2002/00309T patent/TR200200309T2/xx unknown
- 2000-08-03 MX MXPA02001176A patent/MXPA02001176A/es active IP Right Grant
- 2000-08-03 PL PL00353615A patent/PL353615A1/xx unknown
- 2000-08-03 OA OA1200200031A patent/OA12044A/en unknown
- 2000-08-04 PE PE2000000782A patent/PE20010664A1/es not_active Application Discontinuation
- 2000-08-04 CO CO00058852A patent/CO5200853A1/es not_active Application Discontinuation
- 2000-08-04 AR ARP000104030A patent/AR028158A1/es not_active Application Discontinuation
2002
- 2002-01-22 IS IS6244A patent/IS6244A/is unknown
- 2002-01-23 ZA ZA200200605A patent/ZA200200605B/xx unknown
- 2002-01-25 CR CR6572A patent/CR6572A/es not_active Application Discontinuation
- 2002-02-04 NO NO20020545A patent/NO20020545L/no not_active Application Discontinuation
- 2002-02-21 BG BG06424A patent/BG106424A/bg unknown
2005
- 2005-09-14 US US11/227,214 patent/US7083805B2/en not_active Expired - Fee Related
2007
- 2007-07-26 US US11/881,230 patent/US20080019925A1/en not_active Abandoned

Also Published As

Publication number	Publication date
YU7602A (sh)	2004-09-03
MXPA02001176A (es)	2002-07-02
EP1206280A1 (en)	2002-05-22
IS6244A (is)	2002-01-22
CN1368890A (zh)	2002-09-11
ZA200200605B (en)	2003-03-26
HN2000000165A (es)	2001-07-09
JP2003506415A (ja)	2003-02-18
HUP0203796A2 (en)	2003-03-28
PA8499001A1 (es)	2001-12-14
AU6513500A (en)	2001-03-05
NO20020545L (no)	2002-03-27
AR028158A1 (es)	2003-04-30
AU772936B2 (en)	2004-05-13
AP2002002434A0 (en)	2002-03-31
EE200200058A (et)	2003-04-15
WO2001010464A1 (en)	2001-02-15
PE20010664A1 (es)	2001-06-23
EA004895B1 (ru)	2004-08-26
HRP20020199A2 (en)	2004-02-29
CN1216643C (zh)	2005-08-31
CR6572A (es)	2004-04-29
PL353615A1 (en)	2003-12-01
US20060068006A1 (en)	2006-03-30
TR200200309T2 (tr)	2002-06-21
KR20020059358A (ko)	2002-07-12
CN1650844A (zh)	2005-08-10
BG106424A (bg)	2002-09-30
GT200000126A (es)	2002-01-25
CO5200853A1 (es)	2002-09-27
HK1048437A1 (zh)	2003-04-04
EP1206280A4 (en)	2007-10-10
NO20020545D0 (no)	2002-02-04
EA200200089A1 (ru)	2002-08-29
BR0012920A (pt)	2002-04-30
IL147943A0 (en)	2002-08-14
UY26270A1 (es)	2001-03-16
GEP20043376B (en)	2004-08-10
SK1792002A3 (en)	2002-09-10
CA2378591A1 (en)	2001-02-15
AU772936C (en)	2004-12-09
US7083805B2 (en)	2006-08-01
US20080019925A1 (en)	2008-01-24
NZ516741A (en)	2003-10-31
CZ2002207A3 (cs)	2002-06-12